Gyros Protein Technologies, a company based in Sweden, has announced an agreement to merge with US-based company Protein Technologies, Inc.

Gyros provides automated micro-immunoassays for the development of therapeutic proteins, whereas Protein Technologies produces peptide synthesis instrumentation and reagents.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.
"The merger will result in a new company called Gyros Protein Technologies AB, which will be able to grow faster in the areas the two companies are engaged in."

The merger will result in a new company called Gyros Protein Technologies AB, which will be able to grow faster in the areas the two companies are engaged in.

Auris Surgical Robotics has agreed to acquire Hansen Medical, Inc., for $80m in a cash transaction that will involve the purchase of the latter’s shares at a price of $4 per share.

The offer price represents a premium of approximately 39.9% over Hansen Medical’s closing price on NASDAQ on 19 April.

The target company is engaged in the design and manufacture of medical robotics for positioning and control of catheter-based technologies. Auris Surgical Robotics provides robotics technology for medical applications.

The takeover, which is expected to be completed in mid-2016, is expected to enhance the acquirer’s position in the robotics market.

Both companies involved in the transaction are based in the US.